True North Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,474
| Closed | -$1.49M | – | 208 |
|
|
2023
Q1 | $1.49M | Hold |
21,474
| – | – | 0.44% | 53 |
|
|
2022
Q4 | $1.55M | Buy |
21,474
+1
| +0% | +$72 | 0.53% | 50 |
|
|
2022
Q3 | $1.53M | Sell |
21,473
-207
| -1% | -$14.7K | 0.5% | 48 |
|
|
2022
Q2 | $1.67M | Buy |
21,680
+84
| +0.4% | +$6.47K | 0.52% | 47 |
|
|
2022
Q1 | $1.58M | Sell |
21,596
-2,810
| -12% | -$205K | 0.42% | 53 |
|
|
2021
Q4 | $1.52M | Buy |
24,406
+32
| +0.1% | +$1.99K | 0.26% | 86 |
|
|
2021
Q3 | $1.44M | Buy |
24,374
+4,278
| +21% | +$253K | 0.28% | 81 |
|
|
2021
Q2 | $1.34M | Buy |
20,096
+70
| +0.3% | +$4.68K | 0.28% | 78 |
|
|
2021
Q1 | $1.26M | Sell |
20,026
-363
| -2% | -$22.9K | 0.3% | 73 |
|
|
2020
Q4 | $1.26M | Buy |
20,389
+1,000
| +5% | +$62K | 0.32% | 69 |
|
|
2020
Q3 | $1.17M | Sell |
19,389
-262
| -1% | -$15.8K | 0.34% | 66 |
|
|
2020
Q2 | $1.16M | Buy |
+19,651
| New | +$1.16M | 0.28% | 72 |
|